特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

インフルエンザワクチンの世界市場:COVID-19パンデミックにおける医療システムへのストレスの緩和

Global Market Study on Flu Vaccines: Alleviating the Stress on Healthcare Systems amid COVID-19 Pandemic

発行 Persistence Market Research 商品コード 943742
出版日 ページ情報 英文 195 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=107.71円で換算しております。
インフルエンザワクチンの世界市場:COVID-19パンデミックにおける医療システムへのストレスの緩和 Global Market Study on Flu Vaccines: Alleviating the Stress on Healthcare Systems amid COVID-19 Pandemic
出版日: 2020年05月13日 ページ情報: 英文 195 Pages
概要

当レポートでは、世界のインフルエンザワクチン市場を調査し、市場および製品の概要、製品イノベーション・製品開発の動向、新型コロナウイルス感染症 (Covid-19) の影響、その他の市場への影響因子の分析、市場規模の推移・予測、製品タイプ・剤形・流通チャネルなど各種区分別の内訳、地域・主要国別の詳細分析、競合環境、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場カバレッジ/分類
  • 市場の定義/範囲/制限

第3章 主要な市場動向

  • 市場に影響を与える主な動向

第4章 世界のインフルエンザワクチン市場の需要(金額/数量ベース、百万米ドル)分析と予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長率動向分析分析

第5章 市場の背景

  • マクロ経済的要因
    • 世界の医療費支出の見通し
  • 予測要素-関連性と影響
    • 予防接種率
    • インフルエンザとインフルエンザ予防接種についての意識
    • インフルエンザワクチンの入手可能性
    • 各国でのインフルエンザワクチンの需要
    • メーカー間のコラボレーション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会分析

第6章 世界のインフルエンザワクチン市場分析と予測: 製品タイプ別

  • イントロダクション /主な調査結果
  • 過去の市場分析: 製品タイプ
  • 現在および将来の市場分析と予測: 製品タイプ
    • 三価インフルエンザワクチン
    • 四価インフルエンザワクチン
  • 市場魅力分析: 製品タイプ

第7章 世界のインフルエンザワクチン市場分析と予測:剤形別

  • イントロダクション /主な調査結果
  • 過去の市場分析:剤形別
  • 現在および将来の市場分析と予測:剤形別
    • 筋肉内注射
    • 鼻スプレー
    • 皮内注射
  • 市場魅力分析:剤形別

第8章 世界のインフルエンザワクチン市場分析と予測:流通チャネル別

  • イントロダクション /主な調査結果
  • 過去の市場分析:流通チャネル別
  • 現在および将来の市場分析と予測:流通チャネル別
    • 機関投資家向けセールス
    • 小売売上高
  • 市場魅力分析:流通チャネル別

第9章 世界のインフルエンザワクチン市場分析と予測:地域別

  • イントロダクション
  • 過去の市場と規模分析:地域別
  • 現在の市場と規模分析と予測:地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 南アジア
    • 東アジア
    • オセアニア
    • 中東・アフリカ(MEA)
  • 市場の魅力分析:地域別

第10章 北米市場分析と予測

  • イントロダクション
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第11章 ラテンアメリカ市場分析と予測

  • イントロダクション
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第12章 欧州市場の分析と予測

  • イントロダクション
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第13章 南アジア市場分析と予測

  • イントロダクション
  • 価格分析
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第14章 東アジア市場分析と予測

  • イントロダクション
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第15章 オセアニア市場分析および予測

  • イントロダクション
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第16章 中東・アフリカ市場分析と予測

  • イントロダクション
  • 過去の市場と規模動向分析:市場分類法
  • 市場および規模予測:市場分類法別
    • 国別
    • 製品タイプ
    • 剤形別
    • 流通チャネル別
  • 市場の魅力分析
  • 成長要因と制約-影響分析

第17章 市場構造分析

  • 市場分析:企業の階層別(インフルエンザワクチン)
  • トップ企業の 市場シェア分析
  • 市場プレゼンス分析
    • 企業の地域別フットプリント
    • 製品のフットプリント:企業別
    • チャンネルフットプリント:企業別

第18章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合
    • Sanofi Pasteur Inc. (Sanofi S/A)
    • AstraZeneca
    • CSL Ltd. (Seqirus)
    • Abbott
    • GlaxoSmithKline Plc.
    • Serum Institute of India Pvt. Ltd.

第19章 調査手法

図表

List of Tables

  • Table 01: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 02: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 03: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 04: Global Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Region
  • Table 05: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 06: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 07: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 08: North America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 09: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 10: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 11: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 12: Latin America Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 13: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 14: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 15: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 16: Europe Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 17: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 18: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 19: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 20: South Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 21: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 22: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 23: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 24: East Asia Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 25: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 26: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 27: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 28: Oceania Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 29: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Country
  • Table 30: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 31: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 32: MEA Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 33: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 34: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 35: China Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 36: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 37: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 38: India Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel
  • Table 39: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Product Type
  • Table 40: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Dosage Form
  • Table 41: Brazil Flu Vaccine Market Size (US$ Mn) Analysis 2015-2019 and Forecast 2020-2030, By Distribution Channel

List of Figures

  • Figure 01: Flu Vaccine Market Value ($ Mn), By Country (2018)
  • Figure 02: Global Flu Vaccine Market Value Share by Product Type (2019E)
  • Figure 03: Global Flu Vaccine Market Value Share by Dosage Form (2019E)
  • Figure 04: Global Flu Vaccine Market Value Share by Distribution Channel (2019E)
  • Figure 05: Global Flu Vaccine Market Value Share by Region (2019E)
  • Figure 06: Global Flu Vaccine Market Value Analysis (US$ Mn), 2015-2019
  • Figure 07: Global Flu Vaccine Market Value Analysis (US$ Mn), 2020-2030
  • Figure 08: Global Flu Vaccine Market Absolute $ Opportunity, 2015-2019
  • Figure 09: Global Flu Vaccine Market Absolute $ Opportunity, 2020-2030
  • Figure 10: Global Flu Vaccine Market Share Analysis (%) By Product Type, 2020 & 2030
  • Figure 11: Global Flu Vaccine Market Y-o-Y Growth (%) By Product Type, 2020-2030
  • Figure 12: Global Flu Vaccine Market Attractiveness Analysis, By Product Type
  • Figure 13: Global Flu Vaccine Market Share Analysis (%) By Dosage Form, 2020 & 2030
  • Figure 14: Global Flu Vaccine Market Y-o-Y Growth (%) By Dosage Form, 2020-2030
  • Figure 15: Global Flu Vaccine Market Attractiveness Analysis, By Dosage Form
  • Figure 16: Global Flu Vaccine Market Share Analysis (%) By Distribution Channel, 2020 & 2030
  • Figure 17: Global Flu Vaccine Market Y-o-Y Growth (%) By Distribution Channel, 2020-2030
  • Figure 18: Global Flu Vaccine Market Attractiveness Analysis, By Distribution Channel
  • Figure 19: Global Flu Vaccine Market Share Analysis (%) By Region, 2020 & 2030
  • Figure 20: Global Flu Vaccine Market Y-o-Y Growth (%) By Region, 2020-2030
  • Figure 21: Global Flu Vaccine Market Attractiveness Analysis, By Region
  • Figure 22: North America Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 23: North America Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 24: North America Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 25: North America Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 26: North America Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 27: North America Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 28: North America Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 29: North America Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 30: North America Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 31: North America Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 32: North America Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 33: North America Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 34: North America Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 35: North America Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 36: Latin America Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 37: Latin America Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 38: Latin America Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 39: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 40: Latin America Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 41: Latin America Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 42: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 43: Latin America Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 44: Latin America Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 45: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 46: Latin America Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 47: Latin America Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 48: Latin America Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 49: Latin America Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 50: Europe Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 51: Europe Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 52: Europe Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 53: Europe Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 54: Europe Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 55: Europe Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 56: Europe Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 57: Europe Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 58: Europe Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 59: Europe Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 60: Europe Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 61: Europe Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 62: Europe Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 63: Europe Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 64: South Asia Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 65: South Asia Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 66: South Asia Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 67: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 68: South Asia Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 69: South Asia Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 70: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 71: South Asia Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 72: South Asia Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 73: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 74: South Asia Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 75: South Asia Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 76: South Asia Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 77: South Asia Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 78: East Asia Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 79: East Asia Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 80: East Asia Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 81: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 82: East Asia Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 83: East Asia Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 84: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 85: East Asia Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 86: East Asia Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 87: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 88: East Asia Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 89: East Asia Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 90: East Asia Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 91: East Asia Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 92: Oceania Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 93: Oceania Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 94: Oceania Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 95: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 96: Oceania Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 97: Oceania Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 98: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 99: Oceania Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 100: Oceania Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 101: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 102: Oceania Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 103: Oceania Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 104: Oceania Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 105: Oceania Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 106: MEA Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 107: MEA Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 108: MEA Flu Vaccine Market Analysis by Country - 2020 & 2030
  • Figure 109: MEA Flu Vaccine Market Y-o-Y Growth Projections by Country, 2020-2030
  • Figure 110: MEA Flu Vaccine Market Attractiveness Analysis by Country, 2020-2030
  • Figure 111: MEA Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 112: MEA Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 113: MEA Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 114: MEA Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 115: MEA Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 116: MEA Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 117: MEA Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 118: MEA Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 119: MEA Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 120: Emerging Countries Market Value Share (2019 E)
  • Figure 121: Emerging Countries Flu Vaccine Market Value (US$ Mn), By Key Countries, 2014-2029
  • Figure 122: China Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 123: China Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 124: China Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 125: China Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 126: China Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 127: China Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 128: China Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 129: China Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 130: China Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 131: China Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 132: China Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 133: India Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 134: India Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 135: India Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 136: India Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 137: India Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 138: India Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 139: India Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 140: India Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 141: India Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 142: India Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 143: India Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
  • Figure 144: Brazil Flu Vaccine Market Size (US$ Mn), 2015-2019
  • Figure 145: Brazil Flu Vaccine Market Size (US$) & Y-o-Y Growth (%), 2020-2030
  • Figure 146: Brazil Flu Vaccine Market Analysis by Product Type - 2020 & 2030
  • Figure 147: Brazil Flu Vaccine Market Y-o-Y Growth Projections by Product Type, 2020-2030
  • Figure 148: Brazil Flu Vaccine Market Attractiveness Analysis by Product Type, 2020-2030
  • Figure 149: Brazil Flu Vaccine Market Analysis by Dosage Form -2020 & 2030
  • Figure 150: Brazil Flu Vaccine Market Y-o-Y Growth Projections by Dosage Form, 2020-2030
  • Figure 151: Brazil Flu Vaccine Market Attractiveness Analysis by Dosage Form, 2020-2030
  • Figure 152: Brazil Flu Vaccine Market Analysis by Distribution Channel -2020 & 2030
  • Figure 153: Brazil Flu Vaccine Market Y-o-Y Growth Projections by Distribution Channel, 2020-2030
  • Figure 154: Brazil Flu Vaccine Market Attractiveness Analysis by Distribution Channel, 2020-2030
目次

Market Analysis and Opportunity Assessment:

Persistence Market Insights (PMR), in its new publication, outlines the growth trails of 'Flu Vaccine Market' for the period between 2020 and 2030. The study includes a thorough analysis of historical and current trends that can impact the future development of flu vaccine market. It offers various drivers, restrains, challenges, and opportunities in the flu vaccine market. The report brings to fore actionable insights on nodes and internodes of the flu vaccine market that can arm the vendors with necessary information to take critical decision with confidence.

PMR's study covers a key indicator assessment to estimate the growth prospects of the flu vaccine market during the predefined period, along with forecast statistics in terms of value (US$ million). In addition, the report consists of multiple sections explaining the global healthcare spending outlook and awareness about flu and flu vaccination.

Readers can find a detailed taxonomy in the report, along with an incisive outlook on the competitive landscape in flu vaccine market. The study profiles a number of incumbent companies and new entrants in the flu market, wherein, product portfolio, new launches, technological innovations, and dynamic growth strategies of these players have been detailed.

What are the Key Questions Answered in the Flu Vaccine Market Report?

PMR's study assesses the flu vaccine market at both macroscopic and microscopic levels to offer detailed insights that can help determine sustained opportunities for the stakeholders. Exclusive information provided in the flu vaccine market report addresses various important questions required to understand and gain comprehensive knowledge about the market.

Some of these questions are:

  • How is regulatory framework in different nations affecting the growth of flu vaccine market?
  • How has the flu vaccine market performed so far and how will it perform in the next decade?
  • What are winning strategies of key players in the flu vaccine market?
  • What are the opportunities market stakeholders are eyeing to strengthen their position in the global market?
  • What are development risks and competitive threats faced by the flu vaccine market players across different regions?

Research Methodology:

The research methodology followed for obtaining complete information regarding the developments in flu vaccine market involves conducting an in-depth market research with the help of various primary and secondary resources. By analyzing the information gathered through and verified by these resources, analysts could offer exclusive insights on how the flu vaccine market will grow and expand during the predefined period.

Analysts have conducted interviews and discussion with healthcare consultants, CEOs, KOLs, regional officers, and sales managers of companies in the supply chain of flu vaccine drugs. The data obtained through these discussions have contributed to the development of the flu vaccine market report as a primary resource.

Secondary resources referred by the analysts for the compilation of flu vaccine market report include company annual and financial reports_bk_01_01_2020, white papers, industrial association publications, research publications, and leading industry magazines. Other secondary resources are Global Alliance of Vaccine and Immunization (Gavi), International Society of Vaccines, and IFPMA.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Recent Developments
  • 1.3. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market

4. Global Flu Vaccines Market Demand (in Value or Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

  • 4.1. Historical Market Value (US$ Mn) Analysis, 2015-2019
  • 4.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global Healthcare Spending Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Vaccination Rate
    • 5.2.2. Awareness about Flu and Flu Vaccination
    • 5.2.3. Availability of Flu Vaccines
    • 5.2.4. Demand for Flu Vaccines in Different Countries
    • 5.2.5. Collaboration among manufacturers
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2015-2019
  • 6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2020-2030
    • 6.3.1. Trivalent Flu Vaccines
    • 6.3.2. Quadrivalent Flu Vaccines
  • 6.4. Market Attractiveness Analysis By Product Type

7. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Dosage Form

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Mn) Analysis By Dosage Form, 2015-2019
  • 7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Dosage Form, 2020-2030
    • 7.3.1. Intramuscular Injection
    • 7.3.2. Nasal Spray
    • 7.3.3. Intradermal Shot
  • 7.4. Market Attractiveness Analysis By Dosage Form

8. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Distribution Channel

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2015-2019
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2020-2030
    • 8.3.1. Institutional Sales
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Community Clinics
      • 8.3.1.3. Public Health Agencies
      • 8.3.1.4. Workplace Purchasing
    • 8.3.2. Retail Sales
      • 8.3.2.1. Retail Pharmacy
      • 8.3.2.2. Mail Order Pharmacy
  • 8.4. Market Attractiveness Analysis By Distribution Channel

9. Global Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030, by Region

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) and Volume Analysis By Region, 2015-2019
  • 9.3. Current Market Size (US$ Mn) and Volume Analysis and Forecast By Region, 2020-2030
    • 9.3.1. North America
    • 9.3.2. Latin America
    • 9.3.3. Europe
    • 9.3.4. South Asia
    • 9.3.5. East Asia
    • 9.3.6. Oceania
    • 9.3.7. Middle East and Africa (MEA)
  • 9.4. Market Attractiveness Analysis By Region

10. North America Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 10.1. Introduction
  • 10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 10.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 10.3.1. By Country
      • 10.3.1.1. U.S.
      • 10.3.1.2. Canada
    • 10.3.2. By Product Type
    • 10.3.3. By Dosage Form
    • 10.3.4. By Distribution Channel
  • 10.4. Market Attractiveness Analysis
  • 10.5. Drivers and Restraints - Impact Analysis

11. Latin America Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 11.1. Introduction
  • 11.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 11.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 11.3.1. By Country
      • 11.3.1.1. Brazil
      • 11.3.1.2. Mexico
      • 11.3.1.3. Rest of Latin America
    • 11.3.2. By Product Type
    • 11.3.3. By Dosage Form
    • 11.3.4. By Distribution Channel
  • 11.4. Market Attractiveness Analysis
  • 11.5. Drivers and Restraints - Impact Analysis

12. Europe Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 12.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 12.3.1. By Country
      • 12.3.1.1. Germany
      • 12.3.1.2. Italy
      • 12.3.1.3. France
      • 12.3.1.4. U.K.
      • 12.3.1.5. Spain
      • 12.3.1.6. BENELUX
      • 12.3.1.7. Russia
      • 12.3.1.8. Rest of Europe
    • 12.3.2. By Product Type
    • 12.3.3. By Dosage Form
    • 12.3.4. By Distribution Channel
  • 12.4. Market Attractiveness Analysis
  • 12.5. Drivers and Restraints - Impact Analysis

13. South Asia Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 13.1. Introduction
  • 13.2. Pricing Analysis
  • 13.3. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 13.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 13.4.1. By Country
      • 13.4.1.1. India
      • 13.4.1.2. Thailand
      • 13.4.1.3. Indonesia
      • 13.4.1.4. Malaysia
      • 13.4.1.5. Rest of South Asia
    • 13.4.2. By Product Type
    • 13.4.3. By Dosage Form
    • 13.4.4. By Distribution Channel
  • 13.5. Market Attractiveness Analysis
  • 13.6. Drivers and Restraints - Impact Analysis

14. East Asia Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 14.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 14.3.1. By Country
      • 14.3.1.1. China
      • 14.3.1.2. Japan
      • 14.3.1.3. South Korea
    • 14.3.2. By Product Type
    • 14.3.3. By Dosage Form
    • 14.3.4. By Distribution Channel
  • 14.4. Market Attractiveness Analysis
  • 14.5. Drivers and Restraints - Impact Analysis

15. Oceania Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 15.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 15.3.1. By Country
      • 15.3.1.1. Australia
      • 15.3.1.2. New Zealand
    • 15.3.2. By Product Type
    • 15.3.3. By Dosage Form
    • 15.3.4. By Distribution Channel
  • 15.4. Market Attractiveness Analysis
  • 15.5. Drivers and Restraints - Impact Analysis

16. Middle East and Africa Flu Vaccines Market Analysis 2015-2019 and Forecast 2020-2030

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Market Taxonomy, 2015-2019
  • 16.3. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2020-2030
    • 16.3.1. By Country
      • 16.3.1.1. GCC Countries
      • 16.3.1.2. Turkey
      • 16.3.1.3. Northern Africa
      • 16.3.1.4. South Africa
      • 16.3.1.5. Rest of Middle East and Africa
    • 16.3.2. By Product Type
    • 16.3.3. By Dosage Form
    • 16.3.4. By Distribution Channel
  • 16.4. Market Attractiveness Analysis
  • 16.5. Drivers and Restraints - Impact Analysis

17. Market Structure Analysis

  • 17.1. Market Analysis by Tier of Companies (Flu Vaccines)
  • 17.2. Market Share Analysis of Top Players
  • 17.3. Market Presence Analysis
    • 17.3.1. By Regional footprint of Players
    • 17.3.2. Product foot print by Players
    • 17.3.3. Channel Foot Print by Players

18. Competition Analysis

  • 18.1. Competition Dashboard
  • 18.2. Competition Benchmarking
  • 18.3. Competition Deep Dive
    • 18.3.1. Sanofi Pasteur Inc. (Sanofi S/A)
      • 18.3.1.1. Overview
      • 18.3.1.2. Product Portfolio
      • 18.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.1.4. Sales Footprint
      • 18.3.1.5. Strategy Overview
        • 18.3.1.5.1. Marketing Strategy
        • 18.3.1.5.2. Product Strategy
        • 18.3.1.5.3. Channel Strategy
    • 18.3.2. AstraZeneca
      • 18.3.2.1. Overview
      • 18.3.2.2. Product Portfolio
      • 18.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.2.4. Sales Footprint
      • 18.3.2.5. Strategy Overview
        • 18.3.2.5.1. Marketing Strategy
        • 18.3.2.5.2. Product Strategy
        • 18.3.2.5.3. Channel Strategy
    • 18.3.3. CSL Ltd. (Seqirus)
      • 18.3.3.1. Overview
      • 18.3.3.2. Product Portfolio
      • 18.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.3.4. Sales Footprint
      • 18.3.3.5. Strategy Overview
        • 18.3.3.5.1. Marketing Strategy
        • 18.3.3.5.2. Product Strategy
        • 18.3.3.5.3. Channel Strategy
    • 18.3.4. Abbott
      • 18.3.4.1. Overview
      • 18.3.4.2. Product Portfolio
      • 18.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.4.4. Sales Footprint
      • 18.3.4.5. Strategy Overview
        • 18.3.4.5.1. Marketing Strategy
        • 18.3.4.5.2. Product Strategy
        • 18.3.4.5.3. Channel Strategy
    • 18.3.5. GlaxoSmithKline Plc.
      • 18.3.5.1. Overview
      • 18.3.5.2. Product Portfolio
      • 18.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.5.4. Sales Footprint
      • 18.3.5.5. Strategy Overview
        • 18.3.5.5.1. Marketing Strategy
        • 18.3.5.5.2. Product Strategy
        • 18.3.5.5.3. Channel Strategy
    • 18.3.6. Serum Institute of India Pvt. Ltd.
      • 18.3.6.1. Overview
      • 18.3.6.2. Product Portfolio
      • 18.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 18.3.6.4. Sales Footprint
      • 18.3.6.5. Strategy Overview
        • 18.3.6.5.1. Marketing Strategy
        • 18.3.6.5.2. Product Strategy
        • 18.3.6.5.3. Channel Strategy

19. Research Methodology